Leukemia research: Moffitt researchers find dual inhibitor may be safer for CLL patients
2020-07-16
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL. Early-stage CLL patients often do not require therapy, but for those with aggressive disease or who have failed previous treatments, a targeted therapy approach may be necessary. One such targeted therapyContinue Reading
